Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Sanofi SA
SNY
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$40.97
-0.43
-1.04%
Últ. Act.: Oct 21, 4:01 PM
$40.93
-0.47
-1.14%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Privacy Manager
PRO
¿Por qué se mueve?:
Sanofi shares are trading higher after the company and Teva reported Phase ...
Ganancias:
Beneficios de Q3 2026 dentro de 9 días de ahora en vie oct 30th, antes de la apertura del mercado
Sanofi Financials
Sanofi (SNY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D
Sanofi (SNY) Q2 sales hit $13.48B, beating estimates driven by Dupixent's 37.6% surge. Full details on earnings and 2026 outlook.
Vandana Singh
PRO
Sanofi Sees FY2026 Sales $55.789B vs $55.850B Est
Sanofi (NASDAQ:SNY) sees FY2026 sales of $55.789 billion vs $55.850 billion analyst estimate.
Benzinga Newsdesk
PRO
Sanofi Q2 Adj. EPS $1.21 Beats $1.09 Estimate, Sales $13.482B Beat $12.650B Estimate
Sanofi (NASDAQ:SNY) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.09 by 11.01 percent. This is a 34.44 percent increase over earnings of $0.90 per share from the same
Benzinga Newsdesk
Why Novavax Stock Is Trading Higher On Wednesday?
Novavax shares rise after Q1 revenue beat; partnerships, credit facility, and technical levels shape outlook amid shift to net loss.
Vandana Singh
Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe
Regeneron beats Q1 estimates as Eylea HD demand rises, while margins narrow and FDA decisions on manufacturing remain pending.
Vandana Singh
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat
Sanofi, Regeneron win FDA nod for Dupixent in pediatric CSU as Q1 sales beat estimates, driven by strong Dupixent growth.
Vandana Singh
